Sonoma Pharmaceuticals, Inc. (34)
Browse by Contract Category
Contracts
-
SONOMA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM AND STOCK OWNERSHIP GUIDELINES Revised by the Board of Directors on December29, 2022
(Filed With SEC on December 30, 2022)
-
At-The-Market Offering Agreement, by and between the Company and Ladenburg Thalmann & Co. Inc., dated December 23, 2022
(Filed With SEC on December 23, 2022)
-
Amended and Restated Employment Agreement by and between the Company and Bruce Thornton, dated July 22, 2022
(Filed With SEC on July 22, 2022)
-
Exclusive License and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Anlicare International dated January 18, 2022
(Filed With SEC on January 20, 2022)
-
Non-Exclusive Distribution and Supply Agreement between Sonoma Pharmaceuticals, Inc. and Salus Medical, LLC dated January 19, 2022
(Filed With SEC on January 20, 2022)
-
Woodstock Lease Agreement between the Company and Fowler Crossing Partners, LP, dated October 1, 2018
(Filed With SEC on July 10, 2020)
-
Offer letter to Chad White dated September 8, 2022
(Filed With SEC on October 7, 2022)
-
Amended and Restated Employment Agreement by and between the Company and Amy Trombly, dated July 22, 2022
(Filed With SEC on July 22, 2022)
-
Exclusive License and Distribution Agreement between the Company and Dyamed Biotech Pte, Ltd., dated November 4, 2021
(Filed With SEC on November 9, 2021)
-
At-The-Market Offering Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated July 30, 2021
(Filed With SEC on July 30, 2021)
-
Employment Agreement by and between the Company and Bruce Thornton, dated July 1, 2021
(Filed With SEC on July 6, 2021)
-
Employment Agreement by and between the Company and Jerry Dvonch, dated July 1, 2021
(Filed With SEC on July 6, 2021)
-
Employment Agreement by and between the Company and Amy Trombly, dated July 1, 2021
(Filed With SEC on July 6, 2021)
-
Exclusive Supply and Distribution Agreement between the Company and EMC Pharma, LLC, dated March 26, 2021
(Filed With SEC on March 31, 2021)
-
Addendum to Employment Agreement with Amy Trombly, dated January 4, 2020
(Filed With SEC on January 8, 2021)
-
Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Gabriel Science, LLC, effective December 14, 2020
(Filed With SEC on December 17, 2020)
-
Exclusive Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Crown Laboratories, Inc., effective December 4, 2020
(Filed With SEC on December 10, 2020)
-
Amendment No. 1 to the Consulting Agreement between the Company and TechCXO, LLC dated September 10, 2020
(Filed With SEC on September 11, 2020)
-
Offer letter J. Dvonch dated August 10, 2020
(Filed With SEC on September 11, 2020)
-
Licensing Agreement between Sonoma Pharmaceuticals, Inc. and Microsafe Group, effective July 27, 2020
(Filed With SEC on August 6, 2020)
-
Amendment No. 9 to Office Lease Agreement between the Company and SSCOP Properties LLC, dated June 20, 2020
(Filed With SEC on July 10, 2020)
-
Asset Purchase Agreement between Sonoma Pharmaceuticals, Inc. and Infinity Labs SD Inc., dated June 24, 2020
(Filed With SEC on June 29, 2020)
-
Consulting Agreement between the Company and Dr. Robert Northey, dated May 30, 2020
(Filed With SEC on June 4, 2020)
-
Separation and Release Agreement between the Company and Dr. Robert Northey, dated May 29, 2020
(Filed With SEC on June 4, 2020)
-
License, Distribution and Supply Agreement by and between Sonoma Pharmaceuticals, Inc. and Brill International, S.L. dated May 19, 2020
(Filed With SEC on May 26, 2020)
-
Mutual Separation and Release Agreement between the Company and John Dal Poggetto, dated April 14, 2020
(Filed With SEC on April 20, 2020)
-
Consulting Agreement between the Company and TechCXO, LLC effective April 14, 2020
(Filed With SEC on April 20, 2020)
-
Asset Purchase Agreement dated February 21, 2020, between Sonoma Pharmaceuticals, Inc. and Microsafe Group, DMCC
(Filed With SEC on February 27, 2020)
-
Employment Agreement between Sonoma Pharmaceuticals, Inc. and Amy Trombly, effective December 26, 2019
(Filed With SEC on December 31, 2019)
-
Form of Placement Agent Warrant granted to Dawson James Securities, Inc. in connection with the November 2019 public offering
(Filed With SEC on November 29, 2019)
-
Placement Agency Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and Dawson James Securities, Inc., as representative, dated November 26, 2019
(Filed With SEC on November 29, 2019)
-
Employment Agreement between Sonoma Pharmaceuticals, Inc. and Amy Trombly, effective September 25, 2019
(Filed With SEC on October 15, 2019)
-
Employment Agreement between Sonoma Pharmaceuticals, Inc. and John Dal Poggetto, effective September 25, 2019
(Filed With SEC on October 15, 2019)
-
Asset Purchase Agreement dated May 14, 2019, between Sonoma Pharmaceuticals, Inc. and Petagon, Ltd
(Filed With SEC on May 22, 2019)